RISKS OF INTRAVENOUS AMIODARONE IN NEONATES

The courses of two neonates treated with intravenous amiodarone for su praventricular tachyarrhythmia, both of whom developed significant adv erse effects, are reported. A 13-day-old term newborn developed hypoth yroidism after 27 days of mostly intravenous amiodarone for atrioventr icular reciprocating tachycardia and severe heart failure. A one-day o ld, 36 weeks' gestation newborn developed electromechanical dissociati on after receiving an intravenous bolus of amiodarone for rapid atrial flutter. Judicious use of amiodarone is recommended.